Literature DB >> 2492055

Capacities of a newly established thymic stromal cell clone to express Ia antigens and to produce interleukin-6, colony-stimulating factor, and thymic stroma-derived T-cell growth factor.

M Ogata1, H Matsubara, Y Takai, H Kosaka, T Katagiri, H Sano, K Ishimura, H Fujita, T Hamaoka, H Fujiwara.   

Abstract

Thymic stromal cell lines, termed MRL104 and MRL28, have been isolated from long-term liquid cultures of thymic stromal cells from MRL/l mice. The capacities of these parental lines and derived clones to express Ia antigens and to produce cytokines involved in T-cell proliferation and/or differentiation were investigated. Parental lines and their clones did not exhibit a typical fibroblastic, macrophage-like, or epithelial appearance in electron as well as phase-contrast micrographs. These thymic stromal cells seemed to differ from established fibroblast lines in that these thymic stromal cells expressed Ia antigens after exposure to interferon-gamma (IFN-gamma), whereas fibroblast lines did not. They also appeared to differ from macrophage cell lines in that they lacked the expression of Mac-1 antigens on their cell surface and produced no detectable level of interleukin-1 (IL1) before or even after exposure to lipopolysaccharide. When these parental lines and its clones were tested for their ability to produce various types of cytokines, it was revealed that they were capable of producing colony-stimulating factor (CSF), IL6, and thymic stroma-derived T cell growth factor (TSTGF), which was recently described, but were unable to generate other lymphokines and IFNs. Thus these cell lines and clones represent unique features in that they have potentials to express Ia antigens and to produce CSF, IL6, and TSTGF. The biological significance for the expression of these features is discussed in the context of intrathymic T-cell maturation and T-cell repertoire selection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492055     DOI: 10.1002/jlb.45.1.69

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Model for clonal elimination in the thymus.

Authors:  H Kosaka; M Ogata; I Hikita; S Maruo; S Sugihara; H Matsubara; Y Takai; T Hamaoka; H Fujiwara
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  Differentiation of thymocytes from CD3-CD4-CD8- through CD3-CD4-CD8+ into more mature stages induced by a thymic stromal cell clone.

Authors:  Y Tatsumi; A Kumanogoh; M Saitoh; Y Mizushima; K Kimura; S Suzuki; H Yagi; A Horiuchi; M Ogata; T Hamaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  A role for CD9 molecules in T cell activation.

Authors:  X G Tai; Y Yashiro; R Abe; K Toyooka; C R Wood; J Morris; A Long; S Ono; M Kobayashi; T Hamaoka; S Neben; H Fujiwara
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

4.  Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product.

Authors:  P F Mühlradt; H Quentmeier; E Schmitt
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Adhesion of immature thymocytes to thymic stromal cells through fibronectin molecules and its significance for the induction of thymocyte differentiation.

Authors:  K Utsumi; M Sawada; S Narumiya; J Nagamine; T Sakata; S Iwagami; Y Kita; H Teraoka; H Hirano; M Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  An in vitro model for cyclosporin A-induced interference of intrathymic clonal elimination.

Authors:  H Kosaka; H Matsubara; S Sogoh; M Ogata; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.